185 related articles for article (PubMed ID: 25527398)
1. Antinociceptive action against colonic distension by brain orexin in conscious rats.
Okumura T; Nozu T; Kumei S; Takakusaki K; Miyagishi S; Ohhira M
Brain Res; 2015 Feb; 1598():12-7. PubMed ID: 25527398
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin acts centrally to induce an antinociceptive action during colonic distension through the orexinergic, dopaminergic and opioid systems in conscious rats.
Okumura T; Nozu T; Kumei S; Takakusaki K; Ohhira M
Brain Res; 2018 May; 1686():48-54. PubMed ID: 29476749
[TBL] [Abstract][Full Text] [Related]
3. Levodopa acts centrally to induce an antinociceptive action against colonic distension through activation of D2 dopamine receptors and the orexinergic system in the brain in conscious rats.
Okumura T; Nozu T; Kumei S; Takakusaki K; Miyagishi S; Ohhira M
J Pharmacol Sci; 2016 Feb; 130(2):123-7. PubMed ID: 26883457
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A1 receptors mediate the intracisternal injection of orexin-induced antinociceptive action against colonic distension in conscious rats.
Okumura T; Nozu T; Kumei S; Takakusaki K; Miyagishi S; Ohhira M
J Neurol Sci; 2016 Mar; 362():106-10. PubMed ID: 26944127
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the dopaminergic system in the central orexin-induced antinociceptive action against colonic distension in conscious rats.
Okumura T; Nozu T; Kumei S; Takakusaki K; Miyagishi S; Ohhira M
Neurosci Lett; 2015 Sep; 605():34-8. PubMed ID: 26275349
[TBL] [Abstract][Full Text] [Related]
6. Central oxytocin signaling mediates the central orexin-induced visceral antinociception through the opioid system in conscious rats.
Okumura T; Nozu T; Kumei S; Ohhira M
Physiol Behav; 2019 Jan; 198():96-101. PubMed ID: 30342057
[TBL] [Abstract][Full Text] [Related]
7. Central orexin-A increases colonic motility in conscious rats.
Nozu T; Kumei S; Takakusaki K; Ataka K; Fujimiya M; Okumura T
Neurosci Lett; 2011 Jul; 498(2):143-6. PubMed ID: 21575675
[TBL] [Abstract][Full Text] [Related]
8. 5-HT
Okumura T; Nozu T; Ishioh M; Igarashi S; Kumei S; Ohhira M
Naunyn Schmiedebergs Arch Pharmacol; 2020 Aug; 393(8):1419-1425. PubMed ID: 32125460
[TBL] [Abstract][Full Text] [Related]
9. Role of the cannabinoid signaling in the brain orexin- and ghrelin-induced visceral antinociception in conscious rats.
Okumura T; Nozu T; Kumei S; Ohhira M
J Pharmacol Sci; 2018 Jun; 137(2):230-232. PubMed ID: 29958814
[TBL] [Abstract][Full Text] [Related]
10. Central regulatory mechanisms of visceral sensation in response to colonic distension with special reference to brain orexin.
Okumura T; Ishioh M; Nozu T
Neuropeptides; 2021 Apr; 86():102129. PubMed ID: 33636498
[TBL] [Abstract][Full Text] [Related]
11. Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats.
Kajiyama S; Kawamoto M; Shiraishi S; Gaus S; Matsunaga A; Suyama H; Yuge O
Brain Res; 2005 May; 1044(1):76-86. PubMed ID: 15862792
[TBL] [Abstract][Full Text] [Related]
12. Brain orexin improves intestinal barrier function via the vagal cholinergic pathway.
Okumura T; Nozu T; Ishioh M; Igarashi S; Kumei S; Ohhira M
Neurosci Lett; 2020 Jan; 714():134592. PubMed ID: 31678432
[TBL] [Abstract][Full Text] [Related]
13. Central orexin inhibits reflex swallowing elicited by the superior laryngeal nerve via caudal brainstem in the rat.
Kobashi M; Mizutani S; Fujita M; Mitoh Y; Shimatani Y; Matsuo R
Physiol Behav; 2014 May; 130():6-12. PubMed ID: 24637063
[TBL] [Abstract][Full Text] [Related]
14. A selective orexin-1 receptor antagonist, SB334867, blocks 2-DG-induced gastric acid secretion in rats.
Yamada H; Takahashi N; Tanno S; Nagamine M; Takakusaki K; Okumura T
Neurosci Lett; 2005 Mar; 376(2):137-42. PubMed ID: 15698936
[TBL] [Abstract][Full Text] [Related]
15. Intracisternal injection of orexin-A prevents ethanol-induced gastric mucosal damage in rats.
Yamada H; Tanno S; Takakusaki K; Okumura T
J Gastroenterol; 2007 May; 42(5):336-41. PubMed ID: 17530356
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of gastric acid secretion by centrally administered orexin-A in conscious rats.
Takahashi N; Okumura T; Yamada H; Kohgo Y
Biochem Biophys Res Commun; 1999 Jan; 254(3):623-7. PubMed ID: 9920789
[TBL] [Abstract][Full Text] [Related]
17. Intra-periaqueductal gray matter microinjection of orexin-A decreases formalin-induced nociceptive behaviors in adult male rats.
Azhdari Zarmehri H; Semnanian S; Fathollahi Y; Erami E; Khakpay R; Azizi H; Rohampour K
J Pain; 2011 Feb; 12(2):280-7. PubMed ID: 21145791
[TBL] [Abstract][Full Text] [Related]
18. The antinociceptive effect of intravenous imipramine in colorectal distension-induced visceral pain in rats: the role of serotonergic and noradrenergic receptors.
İlkaya F; Bilge SS; Bozkurt A; Baş DB; Erdal A; Çiftçioğlu E; Kesim Y
Pharmacol Biochem Behav; 2014 Jul; 122():1-6. PubMed ID: 24582849
[TBL] [Abstract][Full Text] [Related]
19. Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain.
Cheng JK; Chou RC; Hwang LL; Chiou LC
J Pharmacol Exp Ther; 2003 Dec; 307(3):1065-71. PubMed ID: 14551290
[TBL] [Abstract][Full Text] [Related]
20. Orexin receptor type-1 antagonist SB-334867 decreases morphine-induced antinociceptive effect in formalin test.
Azhdari-Zarmehri H; Esmaeili MH; Sofiabadi M; Haghdoost-Yazdi H
Pharmacol Biochem Behav; 2013 Nov; 112():64-70. PubMed ID: 24125787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
